FR2348201A1 - NEW DRUGS FOR THE TREATMENT OF ISCHEMIC VASCULAR DISORDERS - Google Patents
NEW DRUGS FOR THE TREATMENT OF ISCHEMIC VASCULAR DISORDERSInfo
- Publication number
- FR2348201A1 FR2348201A1 FR7709451A FR7709451A FR2348201A1 FR 2348201 A1 FR2348201 A1 FR 2348201A1 FR 7709451 A FR7709451 A FR 7709451A FR 7709451 A FR7709451 A FR 7709451A FR 2348201 A1 FR2348201 A1 FR 2348201A1
- Authority
- FR
- France
- Prior art keywords
- treatment
- new drugs
- vascular disorders
- ischemic vascular
- ischemic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4144376A JPS52125170A (en) | 1976-04-12 | 1976-04-12 | Pyridine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
FR2348201A1 true FR2348201A1 (en) | 1977-11-10 |
Family
ID=12608501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7709451A Withdrawn FR2348201A1 (en) | 1976-04-12 | 1977-03-30 | NEW DRUGS FOR THE TREATMENT OF ISCHEMIC VASCULAR DISORDERS |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS52125170A (en) |
DE (1) | DE2716125A1 (en) |
FR (1) | FR2348201A1 (en) |
GB (1) | GB1557622A (en) |
SE (1) | SE7704197L (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2467199A1 (en) * | 1979-10-15 | 1981-04-17 | Pfizer | NOVEL ANTI-INFLAMMATORY AND IMMUNOREGULATORY NITROGENIC HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING SAME |
EP0093252A2 (en) * | 1982-05-05 | 1983-11-09 | LUDWIG HEUMANN & CO GMBH | Thiomethylpyridine derivatives, process for their preparation and medicaments containing them |
WO1993012089A1 (en) * | 1991-12-19 | 1993-06-24 | Merz + Co., Gmbh & Co. | New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE31624E (en) * | 1979-11-26 | 1984-07-03 | Forsyth Dental Infirmary For Children | Method of treating inflammation |
US4244956A (en) * | 1979-11-26 | 1981-01-13 | Forsyth Dental Infirmary For Children | Method of treating inflammation |
US4563526A (en) * | 1980-09-19 | 1986-01-07 | Forsyth Dental Infirmary For Children | Substituted 2-(arylmethoxy) phenol compounds for the treatment of inflammation |
US5157053A (en) * | 1985-02-04 | 1992-10-20 | G. D. Searle & Co. | Bicycloalky, tricycloalkyl, azabicycloalkyl, and azatricycloalkyl thio amides used to treat inflammation, allergy, asthma and skin disorders |
US4959364A (en) * | 1985-02-04 | 1990-09-25 | G. D. Searle & Co. | Method of treating inflammation, allergy, asthma and proliferative skin disease using heterocyclic amides |
US5244899A (en) * | 1985-02-04 | 1993-09-14 | G. D. Searle And Co. | Azabicycloalkyl and azatricycloalkyl amides used to treat inflammation, allergy, asthma and skin disorders |
US5225444A (en) * | 1985-02-04 | 1993-07-06 | G. D. Searle & Co. | Disubstituted 4-hydroxyphenylthio anilides |
US5071876A (en) * | 1985-02-04 | 1991-12-10 | G. D. Searle & Co. | Novel disubstituted 4-hydroxyphenylthio anilides |
EP0218782B1 (en) * | 1985-05-20 | 1990-05-16 | G.D. Searle & Co. | Lipoxygenase-inhibiting composition and hydroxyphenylthioalkylcarbonyl compounds |
US5229421A (en) * | 1985-05-20 | 1993-07-20 | G. D. Searle & Co. | Methods and compositions for inhibiting lipoxygenase |
DK377487A (en) * | 1986-07-21 | 1988-01-22 | Otsuka Pharma Co Ltd | P-aminophenol |
DE3712752A1 (en) * | 1987-04-15 | 1988-11-03 | Hoechst Ag | HETEROCYCLIC NEOPHANAL ANALOG, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A PEST CONTROL |
JPS63302851A (en) * | 1987-06-02 | 1988-12-09 | Nippon Medical Supply Corp | Blood bag for preserving platelet |
US5002967A (en) * | 1987-06-05 | 1991-03-26 | G. D. Searle & Co. | Phenolic thioethers, sulfoxides, and disulfides as inhibitors of 5-lipoxygenase |
US4835189A (en) * | 1987-06-05 | 1989-05-30 | G. D. Searle & Co. | Phenolic thioalkylamides as inhibitors of 5-lipoxygenase |
JPH0620523Y2 (en) * | 1989-12-07 | 1994-06-01 | 川澄化学工業株式会社 | Medical container |
ES2093099T3 (en) * | 1990-05-31 | 1996-12-16 | Pfizer | PREPARATION OF SUBSTITUTED PIPERIDINES. |
US5281623A (en) * | 1990-08-27 | 1994-01-25 | Eli Lilly And Company | Method for treating inflammation |
US5082854A (en) * | 1990-09-07 | 1992-01-21 | G. D. Searle & Co. | Method of stimulating superoxide generation |
US5189038A (en) * | 1990-09-07 | 1993-02-23 | G. D. Searle And Co. | Method of stimulating superoxide generation |
CA2088503A1 (en) * | 1990-09-07 | 1992-03-08 | Richard August Mueller | Phenolic thioetheramides as 5-lipoxygenase inhibitors |
LT3339B (en) | 1993-03-05 | 1995-07-25 | Merz & Co Gmbh & Co | New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs |
US5585388A (en) * | 1995-04-07 | 1996-12-17 | Sibia Neurosciences, Inc. | Substituted pyridines useful as modulators of acetylcholine receptors |
US6852878B2 (en) | 1998-05-14 | 2005-02-08 | Atherogenics, Inc. | Thioketals and thioethers for inhibiting the expression of VCAM-1 |
AU2006202461B2 (en) * | 1997-05-14 | 2009-12-03 | Atherogenics, Inc. | Compositions and methods for the inhibition of the expression of VCAM-1 |
EP1695959A1 (en) * | 1997-05-14 | 2006-08-30 | Atherogenics, Inc. | Compouds and methods for the inhibition of the expression of VCAM-1 |
US6670398B2 (en) | 1997-05-14 | 2003-12-30 | Atherogenics, Inc. | Compounds and methods for treating transplant rejection |
ATE294158T1 (en) | 1997-05-14 | 2005-05-15 | Atherogenics Inc | A MONOETHER OF PROBUCOL AND METHODS OF INHIBITING VCAM-1 EXPRESSION |
EP1019034A2 (en) | 1997-07-01 | 2000-07-19 | Atherogenics, Inc. | Antioxidant enhancement of therapy for hyperproliferative conditions |
CO5170498A1 (en) * | 1999-05-28 | 2002-06-27 | Abbott Lab | BIARIL SULFONAMIDS ARE USEFUL AS CELL PROLIFERATION INHIBITORS |
US6521658B1 (en) | 1999-05-28 | 2003-02-18 | Abbott Laboratories | Cell proliferation inhibitors |
US7064139B2 (en) * | 2001-10-29 | 2006-06-20 | Uniroyal Chemical Company, Inc. | Method for treating retroviral infections |
WO2005102323A2 (en) | 2004-04-20 | 2005-11-03 | Atherogenics, Inc. | Process of preparing esters and ethers of probucol and derivatives thereof |
AU2008230861A1 (en) | 2007-03-26 | 2008-10-02 | Salutria Pharmaceuticals, Llc | Methods and compositions of derivatives of probucol for the treatment of diabetes |
CN104045552B (en) * | 2013-03-13 | 2019-06-11 | 江苏先声药业有限公司 | Medicinal compound as neuroprotective agent |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2196332A1 (en) * | 1972-08-16 | 1974-03-15 | Chevron Res |
-
1976
- 1976-04-12 JP JP4144376A patent/JPS52125170A/en active Granted
-
1977
- 1977-03-30 FR FR7709451A patent/FR2348201A1/en not_active Withdrawn
- 1977-04-05 GB GB14443/77A patent/GB1557622A/en not_active Expired
- 1977-04-12 DE DE19772716125 patent/DE2716125A1/en active Pending
- 1977-04-12 SE SE7704197A patent/SE7704197L/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2196332A1 (en) * | 1972-08-16 | 1974-03-15 | Chevron Res |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2467199A1 (en) * | 1979-10-15 | 1981-04-17 | Pfizer | NOVEL ANTI-INFLAMMATORY AND IMMUNOREGULATORY NITROGENIC HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING SAME |
EP0093252A2 (en) * | 1982-05-05 | 1983-11-09 | LUDWIG HEUMANN & CO GMBH | Thiomethylpyridine derivatives, process for their preparation and medicaments containing them |
EP0093252A3 (en) * | 1982-05-05 | 1984-08-22 | Ludwig Heumann & Co Gmbh | Thiomethylpyridine derivatives, process for their preparation and medicaments containing them |
WO1993012089A1 (en) * | 1991-12-19 | 1993-06-24 | Merz + Co., Gmbh & Co. | New bht ether compounds and their use as hypolipidemic and antiatherosclerotic drugs |
Also Published As
Publication number | Publication date |
---|---|
JPS52125170A (en) | 1977-10-20 |
GB1557622A (en) | 1979-12-12 |
DE2716125A1 (en) | 1977-10-27 |
SE7704197L (en) | 1977-10-13 |
JPS6126539B2 (en) | 1986-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2348201A1 (en) | NEW DRUGS FOR THE TREATMENT OF ISCHEMIC VASCULAR DISORDERS | |
SE7601204L (en) | THERAPEUTIC SYSTEM FOR THE ADMINISTRATION OF SCOPOLAMIN TRANSDERMALT | |
FR2333515A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CALCIUM METABOLISM DISORDERS | |
FR2341315A1 (en) | MEDICINES FOR THE TREATMENT OF NEUROPATHIES | |
BE871009Q (en) | TREATMENT OF FUNGAL DISORDERS | |
FR2310769A1 (en) | MEDICINAL PRODUCT FOR THE TREATMENT OF ALOPECIA SEBORRHOEICA | |
FR2310751A1 (en) | NEW USEFUL MEDICINES FOR THE TREATMENT OF PIG DYSENTERY | |
BE842106A (en) | MEDICINES FOR THE TREATMENT OF SCHIZOPHRENIA | |
BE856740A (en) | NEW DRUG COMPOSITION FOR THE TREATMENT OF BILIARY LITHIASIS | |
BE837294A (en) | PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CIRCULATION DISORDERS | |
BE856006A (en) | NEW MEDICINES FOR THE TREATMENT OF LIPID OVERLOAD AND CELLULITE | |
FR2310770A1 (en) | MEDICINAL PRODUCT FOR THE TREATMENT OF ALOPECIA AREATA | |
PT65151A (en) | PROCESS FOR THE PREPARATION OF NEW STABLE PHARMACEUTICAL SOLUTIONS | |
FR3672M (en) | Medicinal product based on nicotinic acid derivatives for the treatment of circulatory disorders. | |
FR2341305A1 (en) | NEW TABLETS AND NEW COMPOSITION FOR THE TREATMENT OF DISORDERS OF THE CEREBRAL CIRCULATORY SYSTEM, AND THEIR PREPARATION | |
FR2310768A1 (en) | MEDICINE FOR THE TREATMENT OF ALOPECIA SENILIS | |
BE860239A (en) | MEDICINAL PREPARATION FOR THE TREATMENT OF MALIGNANT NEOFORMATIONS | |
BE800462A (en) | NEW DRUGS FOR THE PREVENTION AND TREATMENT OF ISCHEMIC DISORDERS | |
ZA7628B (en) | Pharmaceutical preparation for the treatment of circulatory disorders | |
FR2310767A1 (en) | MEDICINE FOR THE TREATMENT OF ALOPECIA CHRONICA DIFFUSA | |
BE861326A (en) | BENZISOTHIAZOLONES FOR THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF TROMBOTIC DISORDERS | |
RO69900A2 (en) | DRUG SOLUTION FOR THE TREATMENT OF AFFECTIONS OF THE NASAL MUCOSA | |
FR2576M (en) | New drug, in particular for the treatment of blood coagulability disorders. | |
BE768809A (en) | NEW MEDICINES USEFUL IN PARTICULAR FOR THE TREATMENT OF HEART DISORDERS | |
BE783053A (en) | THERAPEUTIC PREPARATIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |